Back
ESC2025 Premium Access

Comparison of the 2024 ESC risk-factor clinical likelihood model and an artificial intelligence-based tool for ischemia detection in patients with suspected chronic coronary syndrome referred for PET

Session: Novel non-invasive imaging of coronary artery disease
Topic: Noninvasive Diagnostic Methods
Speaker: Doctor S. Frey (Basel, CH)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Simon Frey

University Hospital Basel, Basel (Switzerland)
0 follower

5 more presentations in this session

Coronary computed tomography angiography-derived high-risk shear stress and plaque metrics identify coronary plaques associated with future acute coronary syndromes

Speaker: Doctor D. Hakim (Boston, US)

Access
Abstract
Slides
Video
Like
Thumbnail

Diagnostic performance of clinical likelihood models to predict abnormal myocardial perfusion in patients with suspected chronic coronary syndrome

Speaker: Doctor J. Soeby (Herning, DK)

Access
Abstract
Slides
Video
Like
Thumbnail

Sex-specific influence of lipoprotein(a) levels on coronary plaque characteristics: the COPRODUCTION-registry

Speaker: Associate Professor P. Breitbart (Bad Krozingen, DE)

Access
Abstract
Slides
Like
Thumbnail

Correlation between thermodilution-based IMR and angio-IMR in the post-heart transplant population

Speaker: Doctor L. Boivin Proulx (Ottawa, CA)

Access
Abstract
Slides
Like
Thumbnail

Relationship between coronary artery calcium score and plaque vulnerability by coronary CT angiography in non-obstructive coronary artery disease

Speaker: Doctor S. Hanseth (Bergen, NO)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Novel non-invasive imaging of coronary artery disease

Speakers: Doctor S. Frey, Doctor D. Hakim, Doctor J. Soeby, Associate Professor P. Breitbart, Doctor L. Boivin Proulx...
Access
Video
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources